LindenJ.V.KaplanH.S.: Transfusion errors: causes and effects.Transf Med Rev, 8: 169–183, 1994.
2.
KleinH.G.: The immunomodulatory effects of blood transfusion.In: Clinical practice of transfusion medicine, PetzLD, SwisherS, KleinmanS, SpenceR, StraussRG (Eds), pp 59–70, Churchill Livingstone, New York, 1996.
3.
WangY.TaoL.MitchellE.BraveryC.BerlingieriP.ArmstrongP.VaughanR.UnderwoodJ.LehnerT.: Allo-immunization elicits CD8+ cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women.Nature Med, 5: 1004–1009, 1999.
4.
OpelzG.SengarD.P.MickeyM.R.TerasakiP.I.: Effect of blood transfusions on subsequent kidney transplants.Transplant Proc, 5: 253–259, 1973.
5.
OpelzG.VanrehterghemY.KirsteG.GrayD.W.HorsburghT.LaChanceJ.G.LarglarderF.LangeH.Vujaklija-StripanovicC.Alvarez-GrandeJ.SchottW.HoyerJ.SchnevelleP.DescoeudresC.RuderH.WujciakT.SchwarzV.: Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients.Transplantation, 63: 964–967, 1997.
6.
VamvakisE.: Transfusion associated cancer recurrence and infection: meta-analysis of the randomized controlled clinical trials.Transfusion, 36: 175–186, 1996.
7.
VamvakisE.C.CarvenJ.H.: Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells.Transfusion, 39: 701–710, 1999.
8.
JensenL.S.: Benefits of leuko-reduced blood transfusion in surgical patients.Curr Opin Hematol, 5: 376–380, 1998.
9.
Van de WateringL.M.HermansJ.HoubiersJ.G.Van der BroekP.J.BouterH.BoerF.HarveyM.S.HuysmansH.A.BrandA.: Beneficial effect of leukocyte depletion of blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial.Circulation, 97: 562–568, 1998.
10.
CoulamC.B.ClarkD.A.CollinsJ.: Worldwide collaborative observational study and metanalysis on allogeneic leukocyte immunotherapy for recurrent spontaneous abortion.Am J Re-prod Immunol, 32: 55–72, 1994.
11.
PetersW.R.FryRD, FleshmanJ.W.KodnerI.J.: Multiple blood transfusions reduce the recurrence rate of Crohn's disease.Dis Colon rectum, 32: 749–753, 1989.
12.
CollierA.C.KalishL.A.BuschM.P.GernsheimerT.AssmannS.F.LaneT.A.AsmuthD.M.LedermanM.M.MurphyE.L.KumarP.KelleyM.FlaniganT.P.McMahonD.K.: Double-blind study of leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: results of the Viral Activation Transfusion Study.Blood (in press).
LeeT.H.PaglieroniT.OhtoH.HollandP.V.BuschM.P.: Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism is severe trauma patients.Blood, 93: 3127–3139, 1999.
15.
VietorH.E.HallenslebenE.van BreeS.M.P.van der MeerE.M.W.KaalS.E.J.Bennebroek-GravenhorstJ.KanhaiH.H.H.BrandA.ClaasF.H.J.: Survival of donor cells 25 years after intrauterine transfusion.Blood, 95: 2709–2714, 2000.
16.
ArtlettC.M.SmithJ.B.JimenezS.A.: Identification of fetal DNA and cells in skin from women with systemic sclerosis.N Engl J Med, 338: 1186, 1998.
BlumbergN.HealJ.M.: The transfusion immunomodulation theory, the Th1/Th2 paradigm and an analogy with pregnancy as a unifying mechanism.Semin Hematol, 33: 329–340, 1996.
19.
GhioM.ContiniP.MazzeiC.BrenciS.BarberisG.FilaciG.IndiveriF.PuppoF.: Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunologic effects of allogeneic blood transfusion.Blood, 93: 12770–12777, 1999.